(NewsNation) — March 26 is Purple Day, a day dedicated to raising awareness about epilepsy worldwide. An estimated 50 million people worldwide are diagnosed with epilepsy, and seizures are the main ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

Epilepsy, also known as seizure disorder, is common, and there are many types. About 1 in 26 people in the U.S. will develop the disease in their lifetime. It affects people of all races, ethnic ...

People often associate seizures and major neurological problems that have convulsions or loss of consciousness. Remember, a brief blank stare, a curious sense of déjà vu, a few seconds of unexplained ...

Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...

There are several types of seizures, such as Tonic-clonic seizures, Absence seizures, Myoclonic seizures, and Atonic seizures ...

Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012 DEE: 63.3% median reduction in major motor seizures REM sleep improvement in patients with Absence Seizures: mean 90% ...

A doctor explains how early recognition and diagnosis of seizures can change the entire course of epilepsy.

Lennox-Gastaut syndrome (LGS) is a rare and severe form of epilepsy, accounting for up to 4 percent of all childhood epilepsy cases. LGS is characterized by three criteria: multiple seizure types, ...

Researchers are optimistic after early results showed that experimental drug treatment zorevunersen may significantly reduce the number of seizures in children with a rare and severe form of epilepsy.